-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EGGxOMPm1w8jap3AFO0RdtzhiWvjyIJB04y8pmsVLHjOBx8DLuwkQNl9tLi8ws+E RQd7LrkQOxcGq5HRsTfyzQ== 0001470930-11-000001.txt : 20110120 0001470930-11-000001.hdr.sgml : 20110120 20110119214801 ACCESSION NUMBER: 0001470930-11-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110120 DATE AS OF CHANGE: 20110119 EFFECTIVENESS DATE: 20110120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOXINESS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001470930 IRS NUMBER: 262157552 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-134194 FILM NUMBER: 11537163 BUSINESS ADDRESS: STREET 1: 750 ALFRED NOBEL DRIVE SUITE 106 CITY: HERCULES STATE: CA ZIP: 94547 BUSINESS PHONE: 510 724 1548 MAIL ADDRESS: STREET 1: 750 ALFRED NOBEL DRIVE SUITE 106 CITY: HERCULES STATE: CA ZIP: 94547 D/A 1 primary_doc.xml X0704 D/A LIVE 0001470930 BIOXINESS PHARMACEUTICALS, INC. 750 ALFRED NOBEL DRIVE SUITE 106 HERCULES CA CALIFORNIA 94547 510 724 1548 CALIFORNIA Bioxiness Health Specialties International None Corporation true 2007 Mansour Bassiri 750 Alfred Nobel Drive, Suite 106 Hercules CA CALIFORNIA 94547 Executive Officer Director Reza Ilkhani 750 Alfred Nobel Drive, Suite 106 Hercules CA CALIFORNIA 94547 Executive Officer Director Clint H. Severson 750 Alfred Nobel Drive, Suite 106 Hercules CA CALIFORNIA 94547 Director Pharmaceuticals Decline to Disclose 06 true 0001470930-09-000001 2009-06-05 false true false 0 2000000 302568 1697432 The exact total amount sold is $302,567.91 and the exact total amount remaining to be sold is $1,697,432.09. false 8 0 0 0 true false BIOXINESS PHARMACEUTICALS, INC. /s/ Reza Ilkhani Reza Ilkhani CFO 2011-01-19 -----END PRIVACY-ENHANCED MESSAGE-----